RNA synthesis inhibitors increase melatonin production in Y79 human retinoblastoma cells

Jina L. Janavs, Mary E. Pierce, Joseph S. Takahashi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Y79 human retinoblastoma cells synthesize melatonin in cell culture thus providing a unique preparation for studying the regulation of melatonin biosynthesis in mammalian retinas. We have previously demonstrated that Y79 cells express NAT and HIOMT activity and produce melatonin in a cAMP- and protein synthesis-dependent manner by increasing NAT, and not HIOMT activity, as has been demonstrated in other retinal and pineal melatonin synthesizing systems. We have extended these studies to investigate the role of RNA synthesis in melatonin regulation, and report here that RNA synthesis inhibitors do not suppress melatonin production in Y79 retinoblastoma cells. Rather, at intermediate concentrations, the inhibitors actinomycin D and camptothecin increase melatonin levels. Camptothecin, a topoisomerase I inhibitor, also increased NAT activity and accumulated cAMP levels in a calcium-dependent manner. This effect on cAMP did not appear to occur through phosphodiesterase, and other regulators of retinal melatonin such as melatonin degradation or components of the dopamine system were unaffected. These results are in contrast with the suppression of melatonin synthesis by RNA synthesis inhibitors observed in rat and chick pineal glands and in chick retinas.

Original languageEnglish (US)
Pages (from-to)47-56
Number of pages10
JournalMolecular Brain Research
Volume23
Issue number1-2
DOIs
StatePublished - 1994

Fingerprint

Nucleic Acid Synthesis Inhibitors
Retinoblastoma
Melatonin
Acetylserotonin O-Methyltransferase
Camptothecin
Retina
Topoisomerase I Inhibitors
Pineal Gland
Phosphoric Diester Hydrolases
Dactinomycin
Dopamine
Cell Culture Techniques
RNA
Calcium

Keywords

  • Actinomycin D
  • cAMP
  • Camptothecin
  • Melatonin
  • N-Acetyltransferase
  • Retinoblastoma
  • RNA synthesis

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

RNA synthesis inhibitors increase melatonin production in Y79 human retinoblastoma cells. / Janavs, Jina L.; Pierce, Mary E.; Takahashi, Joseph S.

In: Molecular Brain Research, Vol. 23, No. 1-2, 1994, p. 47-56.

Research output: Contribution to journalArticle

@article{80dc2f3cc71e47d3bfc6d3fc0f5d16a8,
title = "RNA synthesis inhibitors increase melatonin production in Y79 human retinoblastoma cells",
abstract = "Y79 human retinoblastoma cells synthesize melatonin in cell culture thus providing a unique preparation for studying the regulation of melatonin biosynthesis in mammalian retinas. We have previously demonstrated that Y79 cells express NAT and HIOMT activity and produce melatonin in a cAMP- and protein synthesis-dependent manner by increasing NAT, and not HIOMT activity, as has been demonstrated in other retinal and pineal melatonin synthesizing systems. We have extended these studies to investigate the role of RNA synthesis in melatonin regulation, and report here that RNA synthesis inhibitors do not suppress melatonin production in Y79 retinoblastoma cells. Rather, at intermediate concentrations, the inhibitors actinomycin D and camptothecin increase melatonin levels. Camptothecin, a topoisomerase I inhibitor, also increased NAT activity and accumulated cAMP levels in a calcium-dependent manner. This effect on cAMP did not appear to occur through phosphodiesterase, and other regulators of retinal melatonin such as melatonin degradation or components of the dopamine system were unaffected. These results are in contrast with the suppression of melatonin synthesis by RNA synthesis inhibitors observed in rat and chick pineal glands and in chick retinas.",
keywords = "Actinomycin D, cAMP, Camptothecin, Melatonin, N-Acetyltransferase, Retinoblastoma, RNA synthesis",
author = "Janavs, {Jina L.} and Pierce, {Mary E.} and Takahashi, {Joseph S.}",
year = "1994",
doi = "10.1016/0169-328X(94)90210-0",
language = "English (US)",
volume = "23",
pages = "47--56",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - RNA synthesis inhibitors increase melatonin production in Y79 human retinoblastoma cells

AU - Janavs, Jina L.

AU - Pierce, Mary E.

AU - Takahashi, Joseph S.

PY - 1994

Y1 - 1994

N2 - Y79 human retinoblastoma cells synthesize melatonin in cell culture thus providing a unique preparation for studying the regulation of melatonin biosynthesis in mammalian retinas. We have previously demonstrated that Y79 cells express NAT and HIOMT activity and produce melatonin in a cAMP- and protein synthesis-dependent manner by increasing NAT, and not HIOMT activity, as has been demonstrated in other retinal and pineal melatonin synthesizing systems. We have extended these studies to investigate the role of RNA synthesis in melatonin regulation, and report here that RNA synthesis inhibitors do not suppress melatonin production in Y79 retinoblastoma cells. Rather, at intermediate concentrations, the inhibitors actinomycin D and camptothecin increase melatonin levels. Camptothecin, a topoisomerase I inhibitor, also increased NAT activity and accumulated cAMP levels in a calcium-dependent manner. This effect on cAMP did not appear to occur through phosphodiesterase, and other regulators of retinal melatonin such as melatonin degradation or components of the dopamine system were unaffected. These results are in contrast with the suppression of melatonin synthesis by RNA synthesis inhibitors observed in rat and chick pineal glands and in chick retinas.

AB - Y79 human retinoblastoma cells synthesize melatonin in cell culture thus providing a unique preparation for studying the regulation of melatonin biosynthesis in mammalian retinas. We have previously demonstrated that Y79 cells express NAT and HIOMT activity and produce melatonin in a cAMP- and protein synthesis-dependent manner by increasing NAT, and not HIOMT activity, as has been demonstrated in other retinal and pineal melatonin synthesizing systems. We have extended these studies to investigate the role of RNA synthesis in melatonin regulation, and report here that RNA synthesis inhibitors do not suppress melatonin production in Y79 retinoblastoma cells. Rather, at intermediate concentrations, the inhibitors actinomycin D and camptothecin increase melatonin levels. Camptothecin, a topoisomerase I inhibitor, also increased NAT activity and accumulated cAMP levels in a calcium-dependent manner. This effect on cAMP did not appear to occur through phosphodiesterase, and other regulators of retinal melatonin such as melatonin degradation or components of the dopamine system were unaffected. These results are in contrast with the suppression of melatonin synthesis by RNA synthesis inhibitors observed in rat and chick pineal glands and in chick retinas.

KW - Actinomycin D

KW - cAMP

KW - Camptothecin

KW - Melatonin

KW - N-Acetyltransferase

KW - Retinoblastoma

KW - RNA synthesis

UR - http://www.scopus.com/inward/record.url?scp=0028273931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028273931&partnerID=8YFLogxK

U2 - 10.1016/0169-328X(94)90210-0

DO - 10.1016/0169-328X(94)90210-0

M3 - Article

C2 - 8028483

AN - SCOPUS:0028273931

VL - 23

SP - 47

EP - 56

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -